top of page

CORVIDANE
CORVIDANE Future Equity SAFE 1
Developing a novel, safe drug to prevent heart attacks, strokes and liver transplants for NASH
There is a newer open investment round for this company - click here to view
Our take:
Sign up to receive weekly deal alerts and top news
Round Performance

Amount Raised
[]

Average Investment
[]

Average Per Day
[]

# of Investors
[]
Investors vs. Capital Raised
Investment Type
SAFE
Valuation Cap
$20,000,000
Minimum Investment
$100
Conversion Discount
10%
Investment Details
Early Bird Perks
Perk description | Perk level (dollars) | Perk level (days) |
---|
Loading...
Similar Investments

ACHIEVE CLINICS, INC.
Convertible Note

QMed Innovations
Common Stock

WHITEFLAG
Common Stock
bottom of page